Skip to main content
Log in

Polyester Nanocapsules as New Topical Ocular Delivery Systems for Cyclosporin A

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose. Nanocapsules composed of an oily core (Migliol 840) (MG) surrounded by a poly-ε-caprolactone (PECL) coat were evaluated as potential vehicles for the. topical ocular administration of cyclosporin A (CyA).

Methods. A 23 experimental factorial design was applied to optimize the coating of the oily nanodroplets by a solvent displacement tecnique and to encapsulate a high dose of CyA. The variables investigated were: volume of oil (MG), amount of polymer (PECL), and volume of the organic solvent (acetone) used to dissolve the polymer.

Results. Nanocapsules had a mean size in the range of 210–270 nm, a negative zeta potential (between −55 and −60 mV) and a maximum loading capacity of 50% (CyA/PECL ratio). These highly loaded nano-capsules displayed a thick spongeous polymer coating around the oily nanodroplets. The corneal levels of CyA were up to 5 times higher for the encapsulated CyA than for the oily solution of CyA. In addition, these levels remained significantly higher than those of the control group (oily solution) for up to 3 days. Furthermore, the area-under-the-curve (AUC) values were significantly increased for the encapsulated CyA (319.98) with respect to the oily control (74.34).

Conclusions. The CyA-loaded nanocapsules are shown to be interesting vehicles for the improvement of the ocular penetration of CyA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. R. W. Wood, V. H. K. Li, J. Kreuter and J. R. Robinson. Ocular disposition of poly-hexyl-2-cyano(3-14C) acrylate nanoparticles in the albino rabbit. Int. J. Pharm. 23:175–183 (1985).

    Google Scholar 

  2. C. Losa, P. Calvo, E. Castro, J. L. Vila-Jato and M. J. Alonso. Improvement of ocular penetration of amikacin sulphate by association to poly(butylcyanoacrylate) nanoparticles. J. Pharm. Pharmacol. 43:548–552 (1991)

    Google Scholar 

  3. C. Losa, L. Marchal-Heussler, F. Orallo, J. L. Vila Jato and M. J. Alonso. Design of new formulations for topical ocular administration: polymeric nanocapsules containing metipranolol. Pharm. Res. 10:80–87 (1993)

    Google Scholar 

  4. A. Zimmer, J. Kreuter and J. R. Robinson. Studies on the transport pathway of PBCA nanoparticles in ocular tissues. J. Microencapsulation 8:497–504 (1991).

    Google Scholar 

  5. L. Marchal-Haussler, H. Fessi, J. P. Devissaguet, M. Hoffman and P. Maincent. Colloidal drug delivery systems for the eye. A comparison of the efficacy of three different polymers: polyisobutylcyanoacrylate, polylactic-coglycolic acid, poly-epsilon-caprolactone. S.T.P. Pharm. Sci. 2:98–104 (1992).

    Google Scholar 

  6. P. Calvo, C. Thomas, M. J. Alonso, J. L. Vila Jato and J. R. Robinson. Study of the mechanism of interaction of poly(ε-caprolactone) nanocapsules with the cornea by confocal laser scanning microscopy. Int. J. Pharm. 103:283–291 (1994).

    Google Scholar 

  7. Y. Rojanasakul, Mechanisms of ocular peptide absorption and its enhancement. In D. S. Hsieh (ed.), Drug permeation enhancement, Marcel Dekker, Inc., New York, 1994, pp. 397–410.

    Google Scholar 

  8. J. C. Zhao and X. Y. Jin. Local therapy of corneal allograft rejection with cyclosporine. Am. J. Opthalmol. 119:189–194 (1995).

    Google Scholar 

  9. E. J. Holland, T. W. Olsen, J. M. Ketcham, C. Florine, J. H. Krachmer, J. J. Purcell, S. Lam, H. H. Tessler and J. Sugar. Topical cyclosporin A in the treatment of anterior segment inflammatory disease. Cornea 12:413–419 (1993).

    Google Scholar 

  10. A. G. Palestine, R. B. Nussenblatt and C. C. Chan. Side effects of systemic cyclosporine in patients not undergoing transplantation. Am. J. Med. 77:652–656 (1984).

    Google Scholar 

  11. M. W. Belin, C. S. Bouchard and T. M. Phillips. Update on topical cyclosporin A. Cornea 9:184–195 (1990).

    Google Scholar 

  12. H. Fessi, F. Puisieux, J. P. Devissaguet, N. Ammoury and S. Benita. Nanocapsules formation by interfacial deposition following solvent displacement. Int. J. Pharm. 55:R1–R4 (1989)

    Google Scholar 

  13. S. Bonduelle, C. Foucher, J. C. Leroux, F. Chouinard, C. Cadieux and V. Lenaerts. Association of cyclosporin to isohexylcyanoacrylate nanospheres and subsequent release in human plasma in vitro. J. Microencapsulation 9:173–182 (1992).

    Google Scholar 

  14. U. Pleyer, B. Elkins, D. Rücker, L. Sabine, J. Grammer, J. Chou, K. H. Schmidt and B. J. Mondino. Ocular absorption of cyclosporin A from liposomes incorporated into collagen shields. Curr. Eye Res. 13:177–181 (1994).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Calvo, P., Sánchez, A., Martínez, J. et al. Polyester Nanocapsules as New Topical Ocular Delivery Systems for Cyclosporin A. Pharm Res 13, 311–315 (1996). https://doi.org/10.1023/A:1016015803611

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1016015803611

Navigation